Cellular data is the most popular way to keep online while traveling, with Starlink being a common option for places without a cellular signal. A nomad's data plans need to get laptops, computers, ...

Vice President Kamala Harris gave her definition of what it means to win at the National Action Network. Luka Doncic snubs Mavericks in farewell note to Dallas fans after blockbuster trade How big ...

M.E. At $80, the Spypoint Flex-M rivals the cost of many non-cellular trail cams. Does that mean it's junk? Definitely not. You get a lot of the same great features you get with Spypoint’s Flex ...

So why would you make your trail camera strategy more complicated by throwing in cellular cameras, which require network connection and pairing with apps? Simple, it’s because once you finally have ...

Swiss IoT module maker u-blox is to phase out its loss-making cellular IoT business, the firm has said. The division has over 200 employees; jobs are expected to go with its closure. It made revenue ...

I'm not sure how many of you know today what Nokia once used to mean for all of us ... lead to the creation of the Moon's first-ever cellular network. That's right, a phone network (of sorts ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Most of the non-novelty robots shown at CES bear a functional resemblance to the robots used commercially -- by that I mean you can tell they're the product of the same research in movement and AI ...

Intra-Cellular Therapies (ITCI) shares soared 14.9% in the last trading session to close at $94.87. The move was backed by solid volume with far more shares changing hands than in a normal session.

J&J has offered to buy each share of Intra-Cellular for $132, representing a 39% premium to the stock's closing price on Friday. Shares of Intra-Cellular rose 34% to $128 in afternoon trading ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...